We added the following clinical trials to Metastatic Trial Search for September 2024. To see all clinical trials, please visit Metastatic Trial Search.
ER or PR Positive Trials
- BTX-9341 CDK4/6 Inhibitor with Hormone Therapy for Advanced HR+, HER2- Breast Cancer
- Afuresertib Targeted Therapy with Fulvestrant for Advanced HR+, HER2- Breast Cancer with PIK3CA, AKT1, or PTEN Mutations
HER2 Positive Trials
- Zanidatamab Targeted Therapy with Chemotherapy for Advanced HER2 Positive Breast Cancer
- BL-M07D1 ADC for Advanced HER2 Positive, HER2 Low, and HER2 Expressing Breast Cancer
HER2 Negative Trials
Triple Negative Trials
- CAR-T Cells for Advanced Triple Negative Breast Cancer
- APL-5125 Targeted Therapy for Advanced Triple Negative Breast Cancer
- LY4052031 ADC for Advanced Triple Negative Breast Cancer
- Azenosertib Targeted Therapy with Chemotherapy and Immunotherapy for Advanced Triple Negative Breast Cancer
Other Stage IV Trials
- BRIA-OTS Cell Therapy for Metastatic Breast Cancer
- ASTX727 Targeted Therapy with Olaparib for Advanced Breast Cancer with Certain Mutations
- 186RNL Radioactive Drug for People with Leptomeningeal Metastases
- MDX2001 Immunotherapy for Advanced Breast Cancer
Last Modified on September 3, 2024